Cellumed Co.,Ltd. is engaged in the development of bone graft substitution based on human tissue graft and human recombinant protein for treatment. The company's product portfolio is divided into four categories: allograft is engaged in providing allograft tissues including bio-clearant, hard tissue, soft tissue, skin tissue and spinal spacer; medical device including spinal fixation system, joint replancement, and navigation system; and bio-similar products including BMP2 (bone morphogenetic protein) reagent and BMP2 DBM Get; as well as stem-cell medicine and products related to bio-engineering. Cellumed Co.,Ltd. also operates as a human tissue bank. The company is based in Seoul, South Korea. Cellumed Co.,Ltd. was incorporated in 1985.
Headquarters
9E 402 Acetechnotower, 345-30 Gasan Dong, Geumcheon Gu
Seoul; Seoul;
Postal Code: 425-833
Contact Details: Purchase the Cellumed Co.,Ltd. report to view the information.
Website: http://www.kbbcom.co.kr
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service